|
|
Senior Grant Recipients | | Study of Alterations of Bone Microenvironment Cells in MM Patients in Relationship with Osteolytic Bone Lesions: Identification of Potential New Therapeutic Targets
Nicola Giuliani, MD, PhD
Cattedra Di Ematologia
Universitaria Di Parma
Parma,
Italy |
| |
|
|
Conversion of Antiapoptotic MCL1 to Death-inducing Forms in Multiple Myeloma
Ruth Craig, PhD
Dartmouth Medical School
Dept. of Pharmacology and Toxicology
Hanover, New Hampshire
Dr. Craig's research is funded by a grant from the Member FUNdraiser Afternoon Tea – Carol Klein and Nancy Moses |
| Junior Grant Recipients | | Promoting Osteoblastogenesis with a Novel Clinical Grade Dkk-1 Neutralizing Antibody in the Treatment of Multiple Myeloma Related Bone Disease
Samantha Pozzi, MD
Dana Farber Cancer Institute, Massachusetts General Hospital
Dept. of Medical Oncology
Boston, Massachusetts | | |
| | Preclinical Evaluation of a Novel Small Molecule Multi-cyclin Dependent Kinase Inhibitor, AT7519 in Multiple Myeloma
Loredana Santo, MD
Dana Farber Cancer Institute, Massachusetts General Hospital
Dept. of Medical Oncology
Boston, Massachusetts | | |
| | Targeting Multiple Myeloma with Nanobodies: Study in the 5TMM Model (2nd Year of Funding)
Karin Vanderkerken, Ph.D.
Vrije Universiteit Brussel (VUB)
Brussels, Belgium |
|
IMF Japan AKI Award: in memory of IMF Japan Founder Akira (AKI) Horinouchi |
|
Hiroyuki Shibata, MD
Tohoku University
Sendai, Japan |
|
